OptiBiotix Health PLC (OPTI) Given “Corporate” Rating at FinnCap

OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reissued by stock analysts at FinnCap in a research report issued on Tuesday, July 11th.

OptiBiotix Health PLC (OPTI) traded down 1.16% during midday trading on Tuesday, hitting GBX 64.00. The stock had a trading volume of 3,400 shares. The firm has a 50-day moving average price of GBX 66.01 and a 200-day moving average price of GBX 71.90. OptiBiotix Health PLC has a 1-year low of GBX 59.00 and a 1-year high of GBX 90.00. The firm’s market capitalization is GBX 50.02 million.

COPYRIGHT VIOLATION NOTICE: “OptiBiotix Health PLC (OPTI) Given “Corporate” Rating at FinnCap” was first posted by Markets Daily and is owned by of Markets Daily. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.themarketsdaily.com/2017/08/08/optibiotix-health-plc-opti-earns-corporate-rating-from-finncap-updated-updated-updated.html.

About OptiBiotix Health PLC

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply